Home

(By Mani) Quest Diagnostics Inc. (NYSE: DGX) said it plans to sell its HemoCue diagnostic products business to refocus on diagnostic information services, and its fourth quarter earnings were reduced by 6 cents a share due to Hurricane Sandy.The sale of HemoCue business, which develops point-of-care testing systems, follows the divestiture of OralDNA products business, which was sold in December 2012.
From: istockanalyst.com – Read more

Advertisements